| 5 | 2/1 | 返回列表 |
| 查看: 5900 | 回復: 12 | ||
| 當前只顯示滿足指定條件的回帖,點擊這里查看本話題的所有回帖 | ||
[交流]
ssci2區(qū)投稿現(xiàn)收到大修,請各位友友幫忙看看呀! 已有7人參與
|
||
|
兩月初投的ssci 6.2給回復了 7月14日前上傳文件。 第一次投稿啊,還是自己一個在做學術,沒有團隊,所以跪求友友們幫我看看給給意見!! (第一次寫稿不一定圖片可以加進來,所以把審稿意見等文字版本發(fā)出來了 Referee: 1 Comments to the Author This manuscript studies the impact of two forms of government innovation assistance programs - innovation subsidies and tax refunds - on the R&D production of Chinese pharmaceutical companies. This is a very interesting research topic for us. The study tests a number of hypotheses and draws conclusions through quantitative analysis. However, I would like to see more concrete raw data on the quantitative analysis. Otherwise, I do not find it very convincing. I would also like to see a specific discussion of the differences from previous studies. I believe the paper will be even better if you do so. More specifically, I am worried about the following points. (1) The authors present many hypotheses which are H1a, H1b, H2a, H2b, H3a, H3b, H4a, and H4b and analyze them quantitatively. The variable definitions and descriptive statistics are listed in Table1 and Table2 and the regression results for each model are shown the Table 3, Table 4, Table 5, Table 6, and Table 7. These results are then used to test the hypotheses and draw conclusions. However, the actual contents of Table1 and Table2 are black boxes, and there is no way to verify them. Also, there seems to be no explanation of the model from 1 to 4. (2) Also, regarding the INPI that means the total number of patents in Table 1, the results are not compared and discussed with those of Cappelen et al. (2012) and Moretti and Wilson (2014), which are cited as previous studies. There is no crucial discussion of how the current results in China differ from the results in those other countries and also the reason why in this manuscript. I cannot make an accurate judgment because I lack the materials to make a solid decision. Referee: 2 Comments to the Author Dear Author(s), Overall paper is very well written and meets the required standards. However, a few suggestions are put forward to make its worth reading. 1. Abstract: A paragraph on methodology can make it a comprehensive abstract. 2. Literature review should be updated with a few recent papers i.e. 2020-21 3. Methodology: Page 09, line 36, 'Special Treatment (ST*) need to be defined in comprehensive way for the readers. 4. Moderator: page 11, The author(s) should clearly explain the time line and technique used to collect the primary data. 5. VIF threshold reference is missing. Author(s) may consider to provide even conservative reference due to given results. 6. It was observed that Author(s) have used different styles of result reporting, it may be uniformed with providing beta value and p-values i.e. page 17, line 55-60 7. Discussion and Conclusion: Author(s) must add some references in (Point-2) to strengthen the discussion part as provided in the same section i.e. (1 and 3) 8. Page 30, line 47, I guess it must be competitiveness rather than 'competitive' 9. In my opinion, a separate section on limitations and future research directions can make study worth reading. Editor的主要傾向是:You will see that although the referees find some merit in the paper it is required that substantial revisions be done before we can consider it further. Nevertheless, we do hope that you will be able to undertake the additional work on the paper and look forward to receiving a revised manuscript in due course. 很惶恐!主編的意思是能不能中呢?還有Referee: 1在說的black boxes 是啥意思?是在說我的數(shù)據論證不清晰么?還是在覺得我數(shù)據不真實呢?? 球球了 幫我給點意見吧!。! 比心 |
新蟲 (小有名氣)
新蟲 (正式寫手)
金蟲 (正式寫手)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料學學碩080502 337求調劑-一志愿華中科技大學 +4 | 順順順mr 2026-03-18 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 085601調劑 358分 +3 | zzzzggh 2026-03-20 | 4/200 |
|
|
[考研] 初始318分求調劑(有工作經驗) +3 | 1911236844 2026-03-17 | 3/150 |
|
|
[考研] 二本跨考鄭大材料306英一數(shù)二 +3 | z1z2z3879 2026-03-17 | 3/150 |
|
|
[考研] 化學求調劑 +4 | 臨澤境llllll 2026-03-17 | 5/250 |
|
|
[考研] 華東師范大學-071000生物學-293分-求調劑 +3 | 研究生何瑤明 2026-03-18 | 3/150 |
|
|
[考研] 一志愿 西北大學 ,070300化學學碩,總分287,雙非一本,求調劑。 +3 | 晨昏線與星海 2026-03-18 | 3/150 |
|
|
[考研] 311求調劑 +5 | 冬十三 2026-03-18 | 5/250 |
|
|
[考研] 274求調劑 +10 | S.H1 2026-03-18 | 10/500 |
|
|
[考研] 一志愿南昌大學,327分,材料與化工085600 +9 | Ncdx123456 2026-03-19 | 9/450 |
|
|
[考研] 330求調劑 +4 | 小材化本科 2026-03-18 | 4/200 |
|
|
[考研] 考研調劑求學校推薦 +3 | 伯樂29 2026-03-18 | 5/250 |
|
|
[考研] 藥學383 求調劑 +3 | 藥學chy 2026-03-15 | 5/250 |
|
|
[考研] A區(qū)線材料學調劑 +5 | 周周無極 2026-03-20 | 5/250 |
|
|
[考研] 265求調劑 +12 | 梁梁校校 2026-03-19 | 13/650 |
|
|
[考研] 求調劑 +3 | @taotao 2026-03-20 | 3/150 |
|
|
[考研] 0703化學 305求調劑 +4 | FY_yy 2026-03-14 | 4/200 |
|
|
[考研] 334求調劑 +3 | 志存高遠意在機?/a> 2026-03-16 | 3/150 |
|
|
[考研] 一志愿蘇州大學材料工程(085601)專碩有科研經歷三項國獎兩個實用型專利一項省級立項 +6 | 大火山小火山 2026-03-16 | 8/400 |
|
|
[考研] 0856求調劑 +3 | 劉夢微 2026-03-15 | 3/150 |
|